Benjamin F. Edwards & Company’s Pulmonx LUNG Stock Holding History

Benjamin F. Edwards & Company’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$0	Hold	50	–	–	﹤0.01%	2196
2024 Q1	$0	Hold	50	–	–	﹤0.01%	2195
2023 Q4	$1K	Hold	50	–	–	﹤0.01%	2044
2023 Q3	$1K	Hold	50	–	–	﹤0.01%	1714
2023 Q2	$1K	Hold	50	–	–	﹤0.01%	1717
2023 Q1	$1K	Hold	50	–	–	﹤0.01%	1729
2022 Q4	$0	Hold	50	–	–	﹤0.01%	1878
2022 Q3	$1K	Hold	50	–	–	﹤0.01%	1766
2022 Q2	$1K	Hold	50	–	–	﹤0.01%	1756
2022 Q1	$1K	Hold	50	–	–	﹤0.01%	1714
2021 Q4	$2K	Hold	50	–	–	﹤0.01%	1637
2021 Q3	$2K	Hold	50	–	–	﹤0.01%	1637
2021 Q2	$2K	Hold	50	–	–	﹤0.01%	1628
2021 Q1	$2K	Buy	+50	New	+$2.87K	﹤0.01%	1624

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Benjamin F. Edwards & Company's LUNG Position: Q2 2024 in Review

Benjamin F. Edwards & Company held its Pulmonx (LUNG) position steady in Q2 2024 at 50 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2196.

Benjamin F. Edwards & Company first reported a position in LUNG in Q1 2021 and has held it in 14 quarters since. The position peaked at $2K in Q4 2021. 111 funds tracked by Wall St. Rank hold LUNG as of Q2 2024.

Benjamin F. Edwards & Company held 50 shares of Pulmonx worth $0 as of Q2 2024.
Benjamin F. Edwards & Company left its Pulmonx share count unchanged in Q2 2024.
Pulmonx made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #2196 holding.
Benjamin F. Edwards & Company first reported a position in Pulmonx in Q1 2021 and has held it in 14 quarters since.
Benjamin F. Edwards & Company's Pulmonx position peaked at $2K in Q4 2021.
111 funds tracked by Wall St. Rank held Pulmonx as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.